Post-Marketing Study to Assess the Effectiveness and Safety of RECARBRIO in Chinese Adult Patients With Limited or No Alternative Treatment Options for Susceptible Gram-Negative Bacterial Infections (MK-7655A-035) First published 08/07/2026 Last updated 08/07/2026 EU PAS number:EUPAS1000001027 Study Planned